Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCAAs in COPD Rehabilitation
NCT03644836Completed
- Sponsor
- CHU de Poitiers
- Start
- Jan 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing BCAA + Rehab with Placebo + Rehab (2 arms). Primary endpoint: maximum oxygene uptake at 6 weeks. Started Jan 2015; status: completed.
02
Drugs
Branchamin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03644836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03644836.